Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02833246
Official study title

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Study summary

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Ask AI to explain this study
Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedSMS/MMS text messaging and usual care

The study team can explain what participation involves.

Who it may be forSarcoma · Lung

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 19, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Other
Study type
Interventional
Phase
Not applicable
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Other: SMS/MMS text messaging; Other: usual care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
  • Starting a new treatment regimen that includes a single oral anticancer medication
  • Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
  • Age 18 or older.
  • Ability to speak and read English because we do not have the resources to translate the text messages into other languages.
Reasons someone may not be able to joinExclusion criteria

Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Memorial Sloan Kettering Cancer CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 19, 2018. Always confirm current availability with the study team.

View original record ↗